Kura Oncology Stock News

SAN DIEGO, Feb. 18, 2020 -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment.

Osage University Partners, a Philadelphia-based venture capital firm, today announced the promotion of Kirsten Leute to Partner, University Relations.

Bailard Inc. lifted its stake in shares of Kura Oncology Inc (NASDAQ:KURA) by 14.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional inves

Kura Oncology has a number of positives going for the company. However, there are some major negatives which preclude us from recommending this stock. This is p

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmace

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX ) Mesoblast limited (

Company news slowed somewhat this week, perhaps as some took the federal Martin Luther King Jr. Day holiday away from the office and others recovered from

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX ) Mesoblast limited (

Kura Oncology Inc (NASDAQ:KURA) has received a consensus recommendation of “Buy” from the eleven brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts ha

Kura Oncology (NASDAQ: ]) announced Thursday that its chief medical officer, Antonio Gualberto, would step down on Feb. 7 "to pursue other opportunities."

– Dr. Antonio Gualberto to step down after enabling multiple registrational strategies for tipifarnib, positioning program for success – – Clinical development, regulatory and.

– Dr. Antonio Gualberto to step down after enabling multiple registrational strategies for tipifarnib, positioning program for success – – Clinical...

Kura Oncology Inc (NASDAQ:KURA)’s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $12.65 and last traded at $12.70, with a volume of 24528 shares. Th

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 21) Abbott Laboratories (NYSE: ABT ) Apellis Pharmaceu

Risk and reward are two of the most commonly used words in investing. The two are symbiotic and complement each other perfectly. Where there is more risk, the reward is likely to be more abundant. Of